Use in SpecificPopulations:Renalimpairmentuse describedIndicationsandUsage:DiabetesDosageForm andStrengths:OphthalmicproductDosageForm andStrengths:TransdermalpatchIndicationsandUsage:PainContraindications,Warnings, andPrecautions: Riskof hypoglycemiaDrugInteractions:Interactionwith warfarinDosage andAdministration:Doseadjustmentrequired forrenal impairmentContraindications,Warnings, andPrecautions: Riskof nephrotoxicityDosageForm andStrengths:InjectablemedicationDosageForm andStrengths:Nasal sprayAdverse Reactions:May causedrowsiness/sedationContraindications,Warnings, andPrecautions: BlackBox WarningDrugInteractions:CYP2C9substrateDrugInteractions:CYP2D6inhibitorUse inSpecificPopulations:Geriatric usedescribedPatient CounselingInformation:Advises againstdriving oroperating heavymachineryDrug AbuseandDependence:Risk forDependenceDrugInteractions:CYP3A4inhibitorUse inSpecificPopulations:Pediatric usedescribedContraindications,Warnings, andPrecautions: Riskof C. difficileinfectionDrugInteractions:CYP2C9inhibitorDrug AbuseandDependence:ControlledSubstance(Schedule II-V)Use in SpecificPopulations:Notrecommendedduring lactationIndicationsandUsage:ADHDDrugInteractions:InteractionwithamiodaroneIndications andUsage: Hasmultiple FDA-approvedindications foruseDosage andAdministration:Dose adjustmentrequired forhepaticimpairmentDosageForm andStrengths:VaginalproductContraindications,Warnings, andPrecautions: Riskof bleedingContraindications,Warnings, andPrecautions: Riskof QT prolongationDosage andAdministration:Twice-dailydosingPatientCounselingInformation:Advises limitingsun exposurePatientCounselingInformation:Advises use ofcontraceptionIndicationsand Usage:Anti-infectiveIndicationsand Usage:DepressionDrugInteractions:CYP3A4inducerDosageForm andStrengths:RectalproductIndicationsand Usage:HypertensionDrugInteractions:CYP3A4substrateDrugInteractions:CYP2D6substrateContraindications,Warnings, andPrecautions: Riskof serotoninsyndromePatientCounselingInformation:Containsmissed doseinstructionsDosage andAdministration:Once-dailydosingDrug AbuseandDependence:Risk for Abuse,MisuseHowSupplied/Storageand Handling:Store at roomtemperatureHowSupplied/Storageand Handling:RefrigerationrequiredAdverseReactions:May causeheadacheAdverseReactions:May causeweight gainAdverseReactions:May causenauseaDosage andAdministration:Weekly dosingAdverseReactions:10+ AdverseReactionslistedDosageForm andStrengths:Oral capsuleDrugInteractions:InteractionwithgrapefruitDosageForm andStrengths:Oral tabletDosageForm andStrengths:TopicalproductUse in SpecificPopulations:NotrecommendedduringpregnancyDosageForm andStrengths:InhaledmedicationIndications andUsage:Asthma/COPDDosage Formand Strengths:Extended-releaseformulationContraindications,Warnings, andPrecautions: Riskof hepatotoxicityAdverseReactions:May causeweight lossHowSupplied/Storageand Handling:Protect from lightContraindications,Warnings, andPrecautions: Riskof severe rashContraindications,Warnings, andPrecautions: Riskof respiratorydepressionUse in SpecificPopulations: Hasreproductivetoxicity/teratogenicitywarningDosageForm andStrengths:Oral solutionUse in SpecificPopulations:Hepaticimpairmentuse describedPatientCounselingInformation:Advises avoidingalcoholconsumptionUse in SpecificPopulations:Renalimpairmentuse describedIndicationsandUsage:DiabetesDosageForm andStrengths:OphthalmicproductDosageForm andStrengths:TransdermalpatchIndicationsandUsage:PainContraindications,Warnings, andPrecautions: Riskof hypoglycemiaDrugInteractions:Interactionwith warfarinDosage andAdministration:Doseadjustmentrequired forrenal impairmentContraindications,Warnings, andPrecautions: Riskof nephrotoxicityDosageForm andStrengths:InjectablemedicationDosageForm andStrengths:Nasal sprayAdverse Reactions:May causedrowsiness/sedationContraindications,Warnings, andPrecautions: BlackBox WarningDrugInteractions:CYP2C9substrateDrugInteractions:CYP2D6inhibitorUse inSpecificPopulations:Geriatric usedescribedPatient CounselingInformation:Advises againstdriving oroperating heavymachineryDrug AbuseandDependence:Risk forDependenceDrugInteractions:CYP3A4inhibitorUse inSpecificPopulations:Pediatric usedescribedContraindications,Warnings, andPrecautions: Riskof C. difficileinfectionDrugInteractions:CYP2C9inhibitorDrug AbuseandDependence:ControlledSubstance(Schedule II-V)Use in SpecificPopulations:Notrecommendedduring lactationIndicationsandUsage:ADHDDrugInteractions:InteractionwithamiodaroneIndications andUsage: Hasmultiple FDA-approvedindications foruseDosage andAdministration:Dose adjustmentrequired forhepaticimpairmentDosageForm andStrengths:VaginalproductContraindications,Warnings, andPrecautions: Riskof bleedingContraindications,Warnings, andPrecautions: Riskof QT prolongationDosage andAdministration:Twice-dailydosingPatientCounselingInformation:Advises limitingsun exposurePatientCounselingInformation:Advises use ofcontraceptionIndicationsand Usage:Anti-infectiveIndicationsand Usage:DepressionDrugInteractions:CYP3A4inducerDosageForm andStrengths:RectalproductIndicationsand Usage:HypertensionDrugInteractions:CYP3A4substrateDrugInteractions:CYP2D6substrateContraindications,Warnings, andPrecautions: Riskof serotoninsyndromePatientCounselingInformation:Containsmissed doseinstructionsDosage andAdministration:Once-dailydosingDrug AbuseandDependence:Risk for Abuse,MisuseHowSupplied/Storageand Handling:Store at roomtemperatureHowSupplied/Storageand Handling:RefrigerationrequiredAdverseReactions:May causeheadacheAdverseReactions:May causeweight gainAdverseReactions:May causenauseaDosage andAdministration:Weekly dosingAdverseReactions:10+ AdverseReactionslistedDosageForm andStrengths:Oral capsuleDrugInteractions:InteractionwithgrapefruitDosageForm andStrengths:Oral tabletDosageForm andStrengths:TopicalproductUse in SpecificPopulations:NotrecommendedduringpregnancyDosageForm andStrengths:InhaledmedicationIndications andUsage:Asthma/COPDDosage Formand Strengths:Extended-releaseformulationContraindications,Warnings, andPrecautions: Riskof hepatotoxicityAdverseReactions:May causeweight lossHowSupplied/Storageand Handling:Protect from lightContraindications,Warnings, andPrecautions: Riskof severe rashContraindications,Warnings, andPrecautions: Riskof respiratorydepressionUse in SpecificPopulations: Hasreproductivetoxicity/teratogenicitywarningDosageForm andStrengths:Oral solutionUse in SpecificPopulations:Hepaticimpairmentuse describedPatientCounselingInformation:Advises avoidingalcoholconsumption

BINGO Rx - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
  1. Use in Specific Populations: Renal impairment use described
  2. Indications and Usage: Diabetes
  3. Dosage Form and Strengths: Ophthalmic product
  4. Dosage Form and Strengths: Transdermal patch
  5. Indications and Usage: Pain
  6. Contraindications, Warnings, and Precautions: Risk of hypoglycemia
  7. Drug Interactions: Interaction with warfarin
  8. Dosage and Administration: Dose adjustment required for renal impairment
  9. Contraindications, Warnings, and Precautions: Risk of nephrotoxicity
  10. Dosage Form and Strengths: Injectable medication
  11. Dosage Form and Strengths: Nasal spray
  12. Adverse Reactions: May cause drowsiness/sedation
  13. Contraindications, Warnings, and Precautions: Black Box Warning
  14. Drug Interactions: CYP2C9 substrate
  15. Drug Interactions: CYP2D6 inhibitor
  16. Use in Specific Populations: Geriatric use described
  17. Patient Counseling Information: Advises against driving or operating heavy machinery
  18. Drug Abuse and Dependence: Risk for Dependence
  19. Drug Interactions: CYP3A4 inhibitor
  20. Use in Specific Populations: Pediatric use described
  21. Contraindications, Warnings, and Precautions: Risk of C. difficile infection
  22. Drug Interactions: CYP2C9 inhibitor
  23. Drug Abuse and Dependence: Controlled Substance (Schedule II-V)
  24. Use in Specific Populations: Not recommended during lactation
  25. Indications and Usage: ADHD
  26. Drug Interactions: Interaction with amiodarone
  27. Indications and Usage: Has multiple FDA-approved indications for use
  28. Dosage and Administration: Dose adjustment required for hepatic impairment
  29. Dosage Form and Strengths: Vaginal product
  30. Contraindications, Warnings, and Precautions: Risk of bleeding
  31. Contraindications, Warnings, and Precautions: Risk of QT prolongation
  32. Dosage and Administration: Twice-daily dosing
  33. Patient Counseling Information: Advises limiting sun exposure
  34. Patient Counseling Information: Advises use of contraception
  35. Indications and Usage: Anti-infective
  36. Indications and Usage: Depression
  37. Drug Interactions: CYP3A4 inducer
  38. Dosage Form and Strengths: Rectal product
  39. Indications and Usage: Hypertension
  40. Drug Interactions: CYP3A4 substrate
  41. Drug Interactions: CYP2D6 substrate
  42. Contraindications, Warnings, and Precautions: Risk of serotonin syndrome
  43. Patient Counseling Information: Contains missed dose instructions
  44. Dosage and Administration: Once-daily dosing
  45. Drug Abuse and Dependence: Risk for Abuse, Misuse
  46. How Supplied/Storage and Handling: Store at room temperature
  47. How Supplied/Storage and Handling: Refrigeration required
  48. Adverse Reactions: May cause headache
  49. Adverse Reactions: May cause weight gain
  50. Adverse Reactions: May cause nausea
  51. Dosage and Administration: Weekly dosing
  52. Adverse Reactions: 10+ Adverse Reactions listed
  53. Dosage Form and Strengths: Oral capsule
  54. Drug Interactions: Interaction with grapefruit
  55. Dosage Form and Strengths: Oral tablet
  56. Dosage Form and Strengths: Topical product
  57. Use in Specific Populations: Not recommended during pregnancy
  58. Dosage Form and Strengths: Inhaled medication
  59. Indications and Usage: Asthma/COPD
  60. Dosage Form and Strengths: Extended-release formulation
  61. Contraindications, Warnings, and Precautions: Risk of hepatotoxicity
  62. Adverse Reactions: May cause weight loss
  63. How Supplied/Storage and Handling: Protect from light
  64. Contraindications, Warnings, and Precautions: Risk of severe rash
  65. Contraindications, Warnings, and Precautions: Risk of respiratory depression
  66. Use in Specific Populations: Has reproductive toxicity/teratogenicity warning
  67. Dosage Form and Strengths: Oral solution
  68. Use in Specific Populations: Hepatic impairment use described
  69. Patient Counseling Information: Advises avoiding alcohol consumption